Bernhard Hoffmann's most recent trade in Opus Genetics Inc. was a trade of 29,500 Common Stock done . Disclosure was reported to the exchange on March 13, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Opus Genetics Inc. | Bernhard Hoffmann | SVP of Corp. Dev. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2025 | 29,500 | 185,446 | - | 0 | Common Stock | |
| Opus Genetics Inc. | Bernhard Hoffmann | SVP of Corp. Dev. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2025 | 29,500 | 29,500 | - | - | Employee Stock Option (right to buy) | |
| Opus Genetics Inc. | Bernhard Hoffmann | SVP of Corp. Dev. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.14 per share. | 04 Feb 2025 | 6,751 | 155,946 | - | 1.1 | 7,696 | Common Stock |
| Opus Genetics Inc. | Bernhard Hoffmann | SVP of Corp. Dev. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2024 | 30,000 | 30,000 | - | - | Employee Stock Option (right to buy) | |
| Opus Genetics Inc. | Hoffmann Bernhard | SVP of Corp. Dev. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2024 | 20,000 | 162,697 | - | 0 | Common Stock | |
| Opus Genetics Inc. | Bernhard Hoffmann | SVP of Corp. Dev. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.26 per share. | 10 Jan 2024 | 4,031 | 142,697 | - | 3.3 | 13,161 | Common Stock |
| Opus Genetics Inc. | Bernhard Hoffmann | SVP of Corp. Dev. & Ops & Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2023 | 69,912 | 69,912 | - | - | Employee Stock Option (right to buy) | |
| Opus Genetics Inc. | Bernhard Hoffmann | SVP of Corp. Dev. & Ops & Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2023 | 46,608 | 146,728 | - | 0 | Common Stock | |
| Opus Genetics Inc. | Bernhard Hoffmann | VP of Corp. Dev. & Ops & Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2022 | 42,500 | 42,500 | - | - | Employee Stock Option (right to buy) | |
| Opus Genetics Inc. | Bernhard Hoffmann | VP of Corp. Dev. & Ops & Sec. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2020 | 20,000 | 20,000 | - | - | Employee Stock Option (right to buy) |